<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>RIMSO-50- dimethyl sulfoxide irrigant </strong><br>Mylan Institutional LLC<br></p></div>
<h1>
<span class="Bold">RIMSO-50<span class="Sup">®</span></span><br><span class="Bold">brand of dimethyl sulfoxide irrigation, USP</span>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_db163e8c-5163-403e-9e05-84823769734e"></a><a name="section-1"></a><p></p>
<p class="First">PRESCRIBING INFORMATION</p>
<p><span class="Bold">Rx only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_2a92eae3-38d2-4be2-94b6-75804c479504"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First"><span class="Bold">RIMSO-50<span class="Sup">®</span>(dimethyl sulfoxide) (DMSO) 50% w/w Aqueous Solution for intravesical instillation.</span></p>
<p><span class="Bold">Each mL contains 0.54 gm dimethyl sulfoxide STERILE AND NON-PYROGENIC.</span></p>
<p><span class="Bold">Intravesical instillation for the treatment of interstitial <span class="product-label-link" type="condition" conceptid="195588" conceptname="Cystitis">cystitis</span>.</span></p>
<p><span class="Bold">NOT FOR INTRAMUSCULAR OR INTRAVENOUS INJECTION.</span></p>
<p>The active component of RIMSO-50<span class="Sup">®</span> is dimethyl sulfoxide which has the empirical formula C<span class="Sub">2</span>H<span class="Sub">6</span>OS, and is structurally represented as:</p>
<div class="Figure">
<a name="id239"></a><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=58b25d79-78f2-4953-b0c6-61658dc4ef0d&amp;name=3cda0c5c-23fc-4f9a-bfbc-3f39ac09de9c-01.jpg">
</div>
<p>Dimethyl sulfoxide is a clear, colorless and essentially odorless liquid which is miscible with water and most organic solvents. Other physical characteristics include: molecular weight 78.13, melting point 18.3° C, and a specific gravity of 1.096.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_8174bc3c-cef9-43df-8cbb-c4597010aa3a"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Dimethyl sulfoxide is metabolised in man by oxidation to dimethyl sulfone or by reduction to dimethyl sulfide. Dimethyl sulfoxide and dimethyl sulfone are excreted in the urine and feces. Dimethyl sulfide is eliminated through the breath and skin and is responsible for the characteristic odor from patients on dimethyl sulfoxide medication. Dimethyl sulfone can persist in serum for longer than two weeks after a single intravesical instillation. No residual accumulation of dimethyl sulfoxide has occurred in man or lower animals who have received treatment for protracted periods of time. Following topical application, dimethyl sulfoxide is absorbed and generally distributed in the tissues and body fluids.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_342d6239-5e33-497d-b26b-73a6059a5538"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">RIMSO-50<span class="Sup">®</span> (dimethyl sulfoxide) is indicated for the symptomatic relief of patients with interstitial <span class="product-label-link" type="condition" conceptid="195588" conceptname="Cystitis">cystitis</span>. RIMSO-50<span class="Sup">®</span> has not been approved as being safe and effective for any other indication. There is no clinical evidence of effectiveness of dimethyl sulfoxide in the treatment of <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infections</span> of the urinary tract.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_1589957b-67c5-4c7b-99eb-a4dc8a8f1f39"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">None known.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_fe111457-bc47-4810-a500-dbf68f42fe92"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Dimethyl sulfoxide can initiate the liberation of histamine and there has been occasional <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reaction</span> with topical administration of dimethyl sulfoxide. This <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> has been reported in one patients receiving intravesical RIMSO-50<span class="Sup">®</span>. The physician should be cognizant of this possibility in prescribing RIMSO-50<span class="Sup">®</span>. If anaphylactoid symptoms develop, appropriate therapy should be instituted.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_edd265e2-96c4-48ea-8086-662318764aae"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Changes in the refractive index and lens opacities have been seen in monkeys, dogs and rabbits given high doses of dimethyl sulfoxide chronically. Since lens changes were noted in animals, full eye evaluations, including slit lamp examinations, are recommended prior to and periodically during treatment. </p>
<p>Approximately every six months patients receiving dimethyl sulfoxide should have a biochemical screening, particularly liver and renal function tests, and complete blood count. </p>
<p>Intravesical instillation of RIMSO-50<span class="Sup">®</span> may be harmful to patients with urinary tract malignancy because of dimethyl sulfoxide-induced vasodilation. </p>
<p>Some data indicate that dimethyl sulfoxide potentiates other concomitantly administered medications.</p>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_d9f43bb5-8456-477b-abda-29a72b6c1c75"></a><a name="section-7.1"></a><p></p>
<h2>Pregnancy Category C</h2>
<p class="First">Dimethyl sulfoxide caused teratogenic responses in hamsters, rats and mice when administered intraperitoneally at high doses (2.5 to 12 gm/kg). Oral or topical doses of dimethyl sulfoxide did not cause problems of reproduction in rats, mice and hamsters. Topical doses (5 gm/kg first two days, then 2.5 gm/kg - last eight days) produced terata in rabbits, but in another study, topical doses of 1.1 gm/kg days 3 through 16 of gestation failed to produce any abnormalities. There are no adequate and well controlled studies in pregnant women. Dimethyl sulfoxide should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="i4i_info_patients_id_90eb06db-1fe7-48f3-a2b4-4ec486281ddc"></a><a name="section-7.2"></a><p></p>
<h2>INFORMATION FOR PATIENTS (Patient Copy)</h2>
<p class="First">RIMSO-50<span class="Sup">®</span> is a sterile solution of 50% dimethyl sulfoxide (DMSO) and 50% water that has been approved by the U.S. Food and Drug Administration for use in the symptomatic relief of patients with interstitial <span class="product-label-link" type="condition" conceptid="195588" conceptname="Cystitis">cystitis</span>. </p>
<p>RIMSO-50<span class="Sup">®</span> will be instilled in the bladder on an inpatient or out-patient basis, which will be determined by your physician.</p>
<p>Some data indicate that dimethyl sulfoxide could change the effectiveness of medication(s) that you may be presently receiving. Be sure to mention the name and dosage of all medicines you are taking to your physician before a RIMSO-50<span class="Sup">®</span> instillation.</p>
<p>A garlic-like taste may be noted by the patient within a few minutes after instillation of RIMSO-50<span class="Sup">®</span> (dimethyl sulfoxide). This taste may last several hours. An odor on the breath and skin may be present and remain for up to 72 hours. </p>
<p>Some patients may experience <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> on administration of the drug. Usually this becomes less prominent with repeated administration. </p>
<p>If you are pregnant or nursing, ask your physician about the advisability of using RIMSO-50<span class="Sup">®</span>.</p>
<p>Some eye changes have been observed in animals treated with DMSO in large doses for <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span>. Therefore your doctor may want you to have eye evaluations, including slit lamp examinations prior to and periodically during treatment. </p>
<p>It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when dimethyl sulfoxide is administered to a nursing woman. </p>
<p>Safety and effectiveness in children have not been established.</p>
<p>Information available to be given to the patient is reprinted at the end of this text.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_2895fa80-3ed5-4b2e-9ce2-cc69f5a7759d"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">A garlic-like taste may be noted by the patient within a few minutes after instillation of RIMSO-50<span class="Sup">®</span> (dimethyl sulfoxide). This taste may last several hours and because of the presence of metabolites, an odor on the breath and skin may remain for 72 hours.</p>
<p>Transient <span class="product-label-link" type="condition" conceptid="4126268" conceptname="Chemical cystitis">chemical cystitis</span> has been noted following instillation of dimethyl sulfoxide.</p>
<p>The patient may experience moderately severe <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> on administration. Usually this becomes less prominent with repeated administration.</p>
</div>
<div class="Section" data-sectionCode="42227-9">
<a name="i4i_abuse_dependence_id_d883ee7f-d0c1-4e29-a42b-b8ea851653b3"></a><a name="section-9"></a><p></p>
<h1>DRUG ABUSE AND <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">DEPENDENCE</span></h1>
<p class="First">None known.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="i4i_overdosage_id_1e265fea-1dd8-41c4-8ae9-bd8698298f28"></a><a name="section-10"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">The oral LD<span class="Sub">50</span> of dimethyl sulfoxide in the dog is greater than 10 gm/kg. It is improbable that this dosage level could be obtained with intravesical instillation of RIMSO-50<span class="Sup">®</span> in the patient.</p>
<p>In case of accidental oral ingestion, specific measures should be taken to induce <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span>. Additional measures which may be considered are gastric lavage, activated charcoal and force <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_5cad37c5-632e-4046-a9fc-5404cae90d19"></a><a name="section-11"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Instillation of 50 mL of RIMSO-50<span class="Sup">®</span> (dimethyl sulfoxide) directly into the bladder may be accomplished by catheter or asepto syringe and allow to remain for 15 minutes. Application of an analgesic lubricant gel such as lidocaine jelly to the urethra is suggested prior to insertion of the catheter to avoid spasm. The medication is expelled by spontaneous voiding. It is recommended that the treatment be repeated every two weeks until maximum symptomatic relief is obtained. Thereafter, time intervals between therapy may be increased appropriately.</p>
<p>Administration of oral analgesic medication or suppositories containing belladonna and opium prior to the instillation of RIMSO-50<span class="Sup">®</span> can reduce <span class="product-label-link" type="condition" conceptid="4090870" conceptname="Spasm of bladder">bladder spasm</span>. </p>
<p>In patients with severe interstitial <span class="product-label-link" type="condition" conceptid="195588" conceptname="Cystitis">cystitis</span> with very sensitive bladders, the initial treatment, and possibly the second and third (depending on patient response) should be done under anesthesia. (Saddle block has been suggested).</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_3b2924a5-9b06-447a-be24-c8898dbdb6de"></a><a name="section-12"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Vials contain 50 mL of sterile and non-pyrogenic RIMSO-50<span class="Sup">®</span> (50% w/w dimethyl sulfoxide aqueous solution).</p>
<p>Dimethyl sulfoxide is clear and colorless.</p>
<p>NDC 67457-177-50<br>carton containing a 50 mL vial</p>
<div class="Section" data-sectionCode="44425-7">
<a name="i4i_storage_id_e5a90842-cb2a-43ca-a577-cb1c71a4dcdb"></a><a name="section-12.1"></a><p></p>
<p class="First"><span class="Bold">Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]</span></p>
<p><span class="Bold">Protect from strong light.</span></p>
<p>For additional information concerning RIMSO-50®, contact Mylan Institutional LLC,<br>Rockford, IL 61103.</p>
<p>Manufactured for:<br><span class="Bold">Mylan Institutional LLC</span><br>Rockford, IL 61103 U.S.A.</p>
<p>Manufactured by:<br><span class="Bold">Mylan Institutional</span><br>Galway, Ireland</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_bbcc52b4-2497-4f64-8048-3445ebc858f1"></a><a name="section-13"></a><p></p>
<h1>INFORMATION FOR PATIENTS (Physician Copy)</h1>
<p class="First">RIMSO-50<span class="Sup">®</span> is a sterile solution of 50% dimethyl sulfoxide (DMSO) and 50% water that has been approved by the U.S. Food and Drug Administration for use in the symptomatic relief of patients with interstitial <span class="product-label-link" type="condition" conceptid="195588" conceptname="Cystitis">cystitis</span>.</p>
<p>RIMSO-50<span class="Sup">®</span> will be instilled in the bladder on an inpatient or out-patient basis, which will be determined by your physician.</p>
<p>Some data indicate that dimethyl sulfoxide could change the effectiveness of medication(s) that you may be presently receiving. Be sure to mention the name and dosage of all medicines you are taking to your physician before a RIMSO-50<span class="Sup">®</span> instillation.</p>
<p>A garlic-like taste may be noted by the patient within a few minutes after instillation of RIMSO-50<span class="Sup">®</span> (dimethyl sulfoxide). This taste may last several hours. An odor on the breath and skin may be present and remain for up to 72 hours.</p>
<p>Some patients may experience <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> on administration of the drug. Usually this becomes less prominent with repeated administration.</p>
<p>If you are pregnant or nursing, ask your physician about the advisability of using RIMSO-50<span class="Sup">®</span>.</p>
<p>Some eye changes have been observed in animals treated with DMSO in large doses for <span class="product-label-link" type="condition" conceptid="4088438" conceptname="Prolonged periods">prolonged periods</span>. Therefore your doctor may want you to have eye evaluations, including slit lamp examinations prior to and periodically during treatment.</p>
<p>RIMSO-50®<br>(dimethyl sulfoxide) irrigation, USP                                                                                 0582L103</p>
<p>Mylan Institutional LLC                                                                                 REVISED JULY 2012<br>Rockford, IL 61103 U.S.A.                                                                                      MI:RIMSIG:R2</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_b53eede8-7603-47bc-b3ec-8a96a2185c8b"></a><a name="section-14"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 50 mL Vial</h1>
<p class="First"><span class="Bold">NDC 67457-177-50      50 mL</span></p>
<p><span class="Bold">RIMSO-50<span class="Sup">®</span></span><br><span class="Bold">(dimethyl sulfoxide)</span><br><span class="Bold">irrigation, USP</span></p>
<p><span class="Bold">50 mL </span>(54 gm)</p>
<p>50% w/w Aqueous Solution</p>
<p><span class="Bold">For Irrigation Only</span></p>
<p><span class="Bold">Not for Injection</span></p>
<p><span class="Bold">Rx only     Vial</span></p>
<p>Sterile. Non-pyrogenic.</p>
<p><span class="Bold">Contains:</span> 50% w/w dimethyl<br>sulfoxide in water for injection.</p>
<p><span class="Bold">Usual Dosage:</span> See<br>accompanying prescribing<br>information.</p>
<p><span class="Bold">Store at 20° to 25°C (68° to 77°F).</span><br><span class="Bold">[See USP Controlled Room</span><br><span class="Bold">Temperature.]</span></p>
<p><span class="Bold">Protect from strong light.</span></p>
<p>Manufactured for:<br><span class="Bold">Mylan Institutional LLC</span><br>Rockford, IL 61103 U.S.A.</p>
<p>Manufactured by:<br><span class="Bold">Mylan Institutional</span><br>Galway, Ireland</p>
<p>MI:177:1C:R2</p>
<p><span class="Bold">Mylan.com</span></p>
<div class="Figure">
<a name="id474"></a><img alt="RIMSO-50® (dimethyl sulfoxide) irrigation, USP 50 mL (54 gm) Carton Labels" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=58b25d79-78f2-4953-b0c6-61658dc4ef0d&amp;name=3cda0c5c-23fc-4f9a-bfbc-3f39ac09de9c-02.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>RIMSO-50 		
					</strong><br><span class="contentTableReg">dimethyl sulfoxide irrigant</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:67457-177</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVESICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>Dimethyl Sulfoxide</strong> (Dimethyl Sulfoxide) </td>
<td class="formItem">Dimethyl Sulfoxide</td>
<td class="formItem">0.54 g  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:67457-177-50</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">50 mL in 1 VIAL, GLASS</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA017788</td>
<td class="formItem">04/04/1978</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Mylan Institutional LLC
							(790384502)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 7/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>3cda0c5c-23fc-4f9a-bfbc-3f39ac09de9c</div>
<div>Set id: 58b25d79-78f2-4953-b0c6-61658dc4ef0d</div>
<div>Version: 4</div>
<div>Effective Time: 20120731</div>
</div>
</div> <div class="DistributorName">Mylan Institutional LLC</div></p>
</body></html>
